• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4642359)   Today's Articles (91)   Subscriber (50473)
For: Wolff FC, Dillenburg TL, Venzon Antunes M, Linden R, Comparsi Wagner S, Verza SG. Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile. Biomed Chromatogr 2018;32:e4222. [DOI: 10.1002/bmc.4222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2017] [Revised: 02/09/2018] [Accepted: 02/14/2018] [Indexed: 11/08/2022]
Number Cited by Other Article(s)
1
Jahani M, Fazly Bazzaz BS, Akaberi M, Rajabi O, Hadizadeh F. Recent Progresses in Analytical Perspectives of Degradation Studies and Impurity Profiling in Pharmaceutical Developments: An Updated Review. Crit Rev Anal Chem 2022;53:1094-1115. [PMID: 35108132 DOI: 10.1080/10408347.2021.2008226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/21/2023]
2
Detection of Two Genotoxic Impurities in Drug Substance and Preparation of Imatinib Mesylate by LC–MS/MS. Chromatographia 2020. [DOI: 10.1007/s10337-020-03903-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA